A role for nuclear β-catenin in SNRI antidepressant-induced hippocampal cell proliferation

Neuropharmacology

Volumn 55, Issue 1, 2008, Pages 18-26

  Mostany, Ricardo ^a   Valdizán, Elsa M ^a   Pazos, Angel ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Catenin; AKT; Hippocampus; Neurogenesis; Subgranular zone; Venlafaxine

Indexed keywords

BETA CATENIN; BROXURIDINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NORADRENALIN UPTAKE INHIBITOR; NUCLEAR PROTEIN; PROTEIN KINASE B; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SODIUM CHLORIDE; VENLAFAXINE; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; HIPPOCAMPUS; IMMUNOELECTRON MICROSCOPY; IMMUNOREACTIVITY; MALE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATOR GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTIDEPRESSIVE AGENTS; BETA CATENIN; BROMODEOXYURIDINE; CELL NUCLEUS; CELL PROLIFERATION; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MICROSCOPY, ELECTRON; MODELS, BIOLOGICAL; NEURONS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 45849085732     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.04.012     Document Type: Article

References (54)

1. Altar C.A., Laeng P., Jurata L.W., Brockman J.A., Lemire A., Bullard J., Bukhman Y.V., Young T.A., Charles V., and Palfreyman M.G. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J. Neurosci. 24 (2004) 2667-2677
2. Altar C.A., Whitehead R.E., Chen R., Wortwein G., and Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol. Psychiatry 54 (2003) 703-709
3. Beasley C., Cotter D., and Everall I. An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder. Schizophr. Res. 58 (2002) 63-67
4. Bëíque J.C., de Montigny C., Blier P., and Debonnel G. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine. Br. J. Pharmacol. 125 (1998) 526-532
5. Berrocoso E., and Mico J.A. In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors. J. Pharmacol. Exp. Ther. 322 (2007) 101-107
6. Brazil D.P., and Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26 (2001) 657-664
7. Cadigan K.M., and Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 11 (1997) 3286-3305
8. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
9. Czéh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., and Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12796-12801
10. Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 352 (1998) 1754-1755
11. Dranovsky A., and Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol. Psychiatry 59 (2006) 1136-1143
12. Eisch A.J., Barrot M., Schad C.A., Self D.W., and Nestler E.J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 7579-7584
13. Encinas J.M., Vaahtokari A., and Enikopolov G. Fluoxetine targets early progenitor cells in the adult brain. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8233-8238
14. Felton T.M., Kang T.B., Hjorth S., and Auerbach S.B. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn Schmiedeberg's Arch. Pharmacol. 367 (2003) 297-305
15. Frechilla D., Otano A., and Del Rio J. Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry 22 (1998) 787-802
16. Fumagalli F., Molteni R., Calabrese F., Frasca A., Racagni G., and Riva M.A. Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J. Neurochem. 93 (2005) 1551-1560
17. Gould T.D., Picchini A.M., Einat H., and Manji H.K. Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Curr. Drug Targets 7 (2006) 1399-1409
18. Hajszan T., MacLusky N.J., and Leranth C. Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur. J. Neurosci. 21 (2005) 1299-1303
19. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., and Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
20. 1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J. Neurochem. 87 (2003) 182-194
21. Kaidanovich-Beilin O., Milman A., Weizman A., Pick C.G., and Eldar-Finkelman H. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol. Psychiatry 55 (2004) 781-784
22. Khawaja X., Xu J., Liang J.J., and Barrett J.E. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies. J. Neurosci. Res. 75 (2004) 451-460
23. Lie D.C., Colamarino S.A., Song H.J., Desire L., Mira H., Consiglio A., Lein E.S., Jessberger S., Lansford H., Dearie A.R., and Gage F.H. Wnt signalling regulates adult hippocampal neurogenesis. Nature 437 (2005) 1370-1375
24. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu Rev. Cell. Dev. Biol. 20 (2004) 781-810
25. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
26. Lucas J.J., Hernández F., and Ávila J. Nuclear localization of β-catenin in adult mouse thalamus correlates with low levels of GSK-3β. Neuroreport 10 (1999) 2699-2703
27. Lucas J.J., Hernández F., Gómez-Ramos P., Morán M.A., Hen R., and Ávila J. Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice. EMBO J. 20 (2001) 27-39
28. Madsen T.M., Newton S.S., Eaton M.E., Russell D.S., and Duman R.S. Chronic electroconvulsive seizure up-regulates β-catenin expression in rat hippocampus: role in adult neurogenesis. Biol. Psychiatry 54 (2003) 1006-1014
29. Madsen T.M., Treschow A., Bengzon J., Bolwig T.G., Lindvall O., and Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol. Psychiatry 47 (2000) 1043-1049
30. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20 (2000) 9104-9110
31. Manier D.H., Shelton R.C., and Sulser F. Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?. J. Neural. Transm. 109 (2002) 91-99
32. Mehtonen O.P., Sogaard J., Roponen P., and Behnke K. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group. J. Clin. Psychiatry 61 (2000) 95-100
33. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16 (1996) 2365-2372
34. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1982), Academic Press, Sydney
35. Peters A., Palay S.L., and Webstr H.D. The Fine Structure of The Nervous System (1991), Oxford University Press, New York
36. Perera T.D., Coplan J.D., Lisanby S.H., Lipira C.M., Arif M., Carpio C., Spitzer G., Santarelli L., Scharf B., Hen R., Rosoklija G., Sackeim H.A., and Dwork A.J. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J. Neurosci. 27 (2007) 4894-4901
37. Poirier M.F., and Boyer P. Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. Br. J. Psychiatry 175 (1999) 12-16
38. Richelson E. Biological basis of depression and therapeutic relevance. J. Clin. Psychiatry 52 Suppl. (1991) 4-10
39. Russo-Neustadt A.A., Alejandre H., García C., Ivy A.S., and Chen M.J. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 29 (2004) 2189-2199
40. Sairanen M., Lucas G., Ernfors P., Castren M., and Castren E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 25 (2005) 1089-1094
41. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
42. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3908-3913
43. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., and Ben-Ze'ev A. The cyclinD1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5522-5527
44. Stahl S.M., Entsuah R., and Rudolph R.L. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol. Psychiatry 52 (2002) 1166-1174
45. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., Storm D., and Duman R.S. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci. 20 (2000) 4030-4036
46. Tiraboschi E., Tardito D., Kasahara J., Moraschi S., Pruneri P., Gennarelli M., Racagni G., and Popoli M. Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 29 (2004) 1831-1840
47. Tzanakaki M., Guazzelli M., Nimatoudis I., Zissis N.P., Smeraldi E., and Rizzo F. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia. Int. Clin. Psychopharmacol. 15 (2000) 29-34
48. Vermetten E., Vythilingam M., Southwick S.M., Charney D.S., and Bremner J.D. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol. Psychiatry 54 (2003) 693-702
49. Vythilingam M., Vermetten E., Anderson G.M., Luckenbaugh D., Anderson E.R., Snow J., Staib L.H., Charney D.S., and Bremner J.D. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol. Psychiatry 56 (2004) 101-112
50. West M., Slomianka L., and Gundersen H. Unbiased stereological estimation of the total number of neurons in the subdivision of the rat hippocampus using the optical fractionator. Anat. Rec. 231 (1991) 482-497
51. van de Wetering M., Cavallo R., Dooijes D., van Beest M., van Es J., Loureiro J., Ypma A., Hursh D., Jones T., Bejsovec A., Peifer M., Mortin M., and Clevers H. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88 (1997) 789-799
52. Xu H., Chen Z., He J., Haimanot S., Li X., Dyck L., and Li X.M. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in frat hippocampus. Hippocampus 16 (2006) 551-559
53. Yamada S., Yamamoto M., Ozawa H., Riederer P., and Saito T. Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J. Neural. Transm. 110 (2003) 671-680
54. Yu X., and Malenka R.C. β-Catenin is critical for dendritic morphogenesis. Nat. Neurosci. 6 (2003) 1169-1177